1. Academic Validation
  2. New Promising Compounds with in Vitro Nanomolar Activity against Trypanosoma cruzi

New Promising Compounds with in Vitro Nanomolar Activity against Trypanosoma cruzi

  • ACS Med Chem Lett. 2013 May 7;4(6):538-41. doi: 10.1021/ml400039r.
Laura Friggeri 1 Luigi Scipione 1 Roberta Costi 2 Marcel Kaiser 3 Francesca Moraca 4 Claudio Zamperini 4 Bruno Botta 1 Roberto Di Santo 2 Daniela De Vita 1 Reto Brun 5 Silvano Tortorella 1
Affiliations

Affiliations

  • 1 Dipartimento di Chimica e Tecnologie del Farmaco, "Sapienza" Università di Roma , P.le A. Moro 5, 00185 Rome, Italy.
  • 2 Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, "Sapienza" Università di Roma , P.le A. Moro 5, 00185 Rome, Italy.
  • 3 Department Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute , Socinstrasse 57, CH-4051 Basel, Switzerland.
  • 4 Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena , Via A. Moro 2, 53100 Siena, Italy.
  • 5 Department Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute , Socinstrasse 57, CH-4051 Basel, Switzerland ; University of Basel , Petersplatz 1, CH-4003 Basel, Switzerland.
Abstract

The antiparasitic activity of azole and new 4-aminopyridine derivatives has been investigated. The imidazoles 1 and 3-5 showed a potent in vitro antichagasic activity with IC50 values in the low nanomolar concentration range. The (S)-1, (S)-3, and (S)-5 enantiomers showed (up to) a thousand-fold higher activity than the reference drug benznidazole and furthermore low cytotoxicity on rat myogenic L6 cells.

Keywords

CYP51; Chagas disease; Trypanosoma cruzi; aminopyridine; antiparasitic activity; azole.

Figures